484 related articles for article (PubMed ID: 30862377)
1. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Buszewicz M;
Lancet; 2019 Apr; 393(10180):1505-1516. PubMed ID: 30862377
[TBL] [Abstract][Full Text] [Related]
2. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
3. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Adeleke M; Vickerstaff V; Ambler G; Hunter R; Bunce C; Nathwani N; Barton K;
Ophthalmology; 2023 Feb; 130(2):139-151. PubMed ID: 36122660
[TBL] [Abstract][Full Text] [Related]
4. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
[TBL] [Abstract][Full Text] [Related]
5. Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial.
Vickerstaff V; Ambler G; Bunce C; Xing W; Gazzard G;
Trials; 2015 Nov; 16():517. PubMed ID: 26559142
[TBL] [Abstract][Full Text] [Related]
6. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
Trials; 2015 Sep; 16():406. PubMed ID: 26362541
[TBL] [Abstract][Full Text] [Related]
7. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Barton K; Wormald R; Morris S; Hunter R; Rubin G; Buszewicz M; Ambler G; Bunce C;
Br J Ophthalmol; 2018 May; 102(5):593-598. PubMed ID: 28903966
[TBL] [Abstract][Full Text] [Related]
8. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension.
Rolim-de-Moura CR; Paranhos A; Loutfi M; Burton D; Wormald R; Evans JR
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD003919. PubMed ID: 35943114
[TBL] [Abstract][Full Text] [Related]
9. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial.
Philippin H; Matayan E; Knoll KM; Macha E; Mbishi S; Makupa A; Matsinhe C; da Gama V; Monjane M; Ncheda AJ; Mulobuana FA; Muna E; Fopoussi N; Gazzard G; Marques AP; Shah P; Macleod D; Makupa WU; Burton MJ
Lancet Glob Health; 2021 Nov; 9(11):e1589-e1599. PubMed ID: 34655547
[TBL] [Abstract][Full Text] [Related]
10. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics.
Konstantakopoulou E; Gazzard G; Vickerstaff V; Jiang Y; Nathwani N; Hunter R; Ambler G; Bunce C;
Br J Ophthalmol; 2018 May; 102(5):599-603. PubMed ID: 28982956
[TBL] [Abstract][Full Text] [Related]
11. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma.
McIlraith I; Strasfeld M; Colev G; Hutnik CM
J Glaucoma; 2006 Apr; 15(2):124-30. PubMed ID: 16633226
[TBL] [Abstract][Full Text] [Related]
12. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology; 2019 Sep; 126(9):1238-1248. PubMed ID: 31028768
[TBL] [Abstract][Full Text] [Related]
13. Selective Laser Trabeculoplasty as a Substitute for Medications in Patients with Mild-to-moderate Glaucoma in the Brazilian Public Health System.
Barbosa LEO; Barboza WL; Guedes RP; Pereira CDR; Susanna R; Hatanaka M
J Glaucoma; 2024 May; 33(5):303-309. PubMed ID: 38129951
[TBL] [Abstract][Full Text] [Related]
14. 24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients.
Shi Y; Zhang Y; Sun W; Huang AS; Chen S; Zhang L; Wang W; Xie L; Xie X
Sci Rep; 2023 Jul; 13(1):12179. PubMed ID: 37500642
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy of selective laser trabeculoplasty as initial or adjunctive treatment for primary open-angle glaucoma.
Gračner T
Eur J Ophthalmol; 2019 Sep; 29(5):524-531. PubMed ID: 30229662
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.
Woo DM; Healey PR; Graham SL; Goldberg I
Clin Exp Ophthalmol; 2015; 43(4):320-7. PubMed ID: 25287743
[TBL] [Abstract][Full Text] [Related]
17. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial.
Katz LJ; Steinmann WC; Kabir A; Molineaux J; Wizov SS; Marcellino G;
J Glaucoma; 2012 Sep; 21(7):460-8. PubMed ID: 21543992
[TBL] [Abstract][Full Text] [Related]
18. Laser trabeculoplasty for open angle glaucoma.
Rolim de Moura C; Paranhos A; Wormald R
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003919. PubMed ID: 17943806
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation.
Kent SS; Hutnik CM; Birt CM; Damji KF; Harasymowycz P; Si F; Hodge W; Pan I; Crichton A
J Glaucoma; 2015; 24(5):344-7. PubMed ID: 23835670
[TBL] [Abstract][Full Text] [Related]
20. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial.
Ang GS; Fenwick EK; Constantinou M; Gan ATL; Man REK; Casson RJ; Finkelstein EA; Goldberg I; Healey PR; Pesudovs K; Sanmugasundram S; Xie J; McIntosh R; Jackson J; Wells AP; White A; Martin K; Walland MJ; Crowston JG; Lamoureux EL
Br J Ophthalmol; 2020 Jun; 104(6):813-821. PubMed ID: 31488427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
